Battery Ventures Completes Take-Private Transaction with Enzo Biochem
BroadOak Capital Partners advised the Board of Directors of Enzo Biochem on strategic alternatives and the take-private transaction by Battery Ventures. The full press release is below. BOSTON–Battery Ventures, a global, technology-focused investment firm, announced the completion of its take-private of Enzo Biochem (“Enzo”), a life-science research reagents company. Enzo offers over 200,000 research reagents, […]
Scientific Industries completes the divestiture of its Genie division to Troemner, a subsidiary of Mettler-Toledo
BroadOak Capital Partners advised Scientific Industries on the divestiture of its Genie division. The full press release is below. BOHEMIA, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) — Scientific Industries Inc. (OTCQB: SCND) (the “Company”) announced that it has sold its Genie Division to Troemner, LLC, a manufacturing sister company of OHAUS Corporation, (the “Buyer”) for […]
Pluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations
We’re pleased to share that Pluristyx, a BroadOak Capital Partners portfolio company, has recently completed an investment round to expand inventory with new clinical grade cell lines. This strategic investment will enable Pluristyx to be the industry leader offering the highest quality stem cells available anywhere. The full press release is below. Seattle, Washington: July […]
Particle Dynamics acquires EuroAPI UK
We’re pleased to share that Particle Dynamics, a BroadOak Capital Partners portfolio company, has acquired EuroAPI UK Ltd., a commercial spray drying facility in Haverhill, UK. This acquisition expands Particle Dynamics’ global GMP-compliant manufacturing capacity and strengthens their position as a leading CDMO to meet growing demand for improved bioavailability, solubility and stability of therapeutic […]
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio
BroadOak Capital Partners is pleased to share that Halo Labs has been acquired by Waters Corporation. BroadOak has supported Halo Labs for years as the company grew. This acquisition is a powerful validation of Halo’s vision, team, and technology. It also reflects the growing demand for advanced analytical tools that ensure safety and quality in […]
Rubicon Founders Invests in Horizon Infusions
BroadOak Capital Partners is pleased to share that Rubicon Founders has invested in Horizon Infusions. BroadOak has supported Horizon Infusions for several years as the company grew from a single location to nearly two-dozen. With increased interest and support, Horizon Infusions’ excellent team and business model will continue to scale to meet growing customer demand. […]
Werfen acquires Omixon
BroadOak Capital Partners advised Omixon on its sale of the company to Werfen. Omixon, a privately held company based in Budapest, Hungary, develops and commercializes NGS technology for transplant diagnostics. The full press release is below. October 16, 2024 (Barcelona, Spain): Werfen announced today that it has completed the acquisition of Omixon after obtaining all […]
PAK BioSolutions Raises $12 Million Series A to Expand Continuous Biomanufacturing Product Line
BroadOak Capital Partners invested in PAK Biosolutions to expand their commercial and product development. The full press release is below. Vienna, VA: Today, PAK BioSolutions announced that it has raised $12M from Arboretum Ventures, BroadOak Capital Partners, and other investors to expand commercial and product development efforts for its line of automated continuous manufacturing systems […]
LabConnect Acquires A4P Bio
BroadOak Capital Partners advised LabConnect on its acquisition of A4P Bio. A4P Bio provides bioanalytical project management solutions and consultancy for clinical trials. The full press release is below. JOHNSON CITY, Tenn., April 22, 2024 /PRNewswire/ — LabConnect has announced the acquisition of A4P Consulting Ltd (A4P), a scientific consultancy company, specializing in bioanalytical and biosample project […]
ZoBio Sells to Oncodesign Services
BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is a leading provider of biophysics-based small molecule drug discovery services. The full press release is below. Dijon, France & Leiden, The Netherlands, January 23rd, 2024 – Oncodesign Services (ODS), a leading Contract Research Organization specialized in drug discovery and […]